Glutathione depletion increases tyrosinase activity in human melanoma cells

J Invest Dermatol. 1993 Dec;101(6):871-4. doi: 10.1111/1523-1747.ep12371709.

Abstract

The aim of the present work was to estimate the effect of intracellular glutathione depletion on melanogenesis in human melanoma cells. We determined tyrosine hydroxylation activity, the rate-limiting step of the pathway, and 14C-melanin formation, an assay reflecting the global eumelanogenic pathway. Intracellular glutathione was depleted by treatment with buthionine-S-sulfoximine, a well-known inhibitor of gamma-glutamylcysteine synthetase. The intracellular depletion of glutathione was substantial after 20 h of incubation with 50 microM buthionine-S-sulfoximine, although a significant effect could be observed after 6 h. Tyrosine hydroxylase activity increased in parallel with glutathione depletion, to reach 160% with respect to the control values during 24 h of buthionine-S-sulfoximine treatment. We have found the response to buthionine-S-sulfoximine to be dose dependent and the two different human cell lines HBL and LND1 to have similar, if not identical, responses. 14C-melanin formation assay revealed even greater activation, up to 400% of the control values. This indicates that glutathione depletion may have two distinct effects: first, a direct one on tyrosinase activity and, second, an effect on the promotion of eumelanogenesis. The stimulation of tyrosine hydroxylase can be explained by a possible inactivation of the enzyme by endogenous thiol compounds rather than by a direct effect of buthionine-S-sulfoximine itself on tyrosinase. The data suggest that thiol compounds may play a role for stimulation of melanogenesis by ultraviolet radiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology
  • Buthionine Sulfoximine
  • Glutathione / deficiency*
  • Humans
  • Melanins / biosynthesis
  • Melanoma / enzymology*
  • Melanoma / pathology
  • Methionine Sulfoximine / analogs & derivatives
  • Methionine Sulfoximine / pharmacology
  • Monophenol Monooxygenase / metabolism*
  • Sulfhydryl Compounds / pharmacology
  • Time Factors
  • Tumor Cells, Cultured
  • Tyrosine 3-Monooxygenase / antagonists & inhibitors
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Antimetabolites, Antineoplastic
  • Melanins
  • Sulfhydryl Compounds
  • Methionine Sulfoximine
  • Buthionine Sulfoximine
  • Tyrosine 3-Monooxygenase
  • Monophenol Monooxygenase
  • Glutathione